Insulin After More Than 90 Years

Insulin After More Than 90 Years

Open Access
Technosphere Inhaled Insulin: Is Faster Better?
Jack L. Leahy

Diabetes Care Dec 2015, 38 (12) 2282-2284; DOI: 10.2337/dci15-0002
You have access
Inhaled Technosphere Insulin Versus Inhaled Technosphere Placebo in Insulin-Naïve Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetes Agents
Julio Rosenstock, Denise Franco, Vadym Korpachev, Brad Shumel, Yuhui Ma, Robert Baughman, Nikhil Amin, Janet B. McGill

Diabetes Care Dec 2015, 38 (12) 2274-2281; DOI: 10.2337/dc15-0629
Open Access
Inhaled Technosphere Insulin Compared With Injected Prandial Insulin in Type 1 Diabetes: A Randomized 24-Week Trial
Bruce W. Bode, Janet B. McGill, Daniel L. Lorber, Jorge L. Gross, P.-C. Chang, David B. Bregman

Diabetes Care Dec 2015, 38 (12) 2266-2273; DOI: 10.2337/dc15-0075
Open Access
Efficacy and Safety of Canagliflozin, a Sodium–Glucose Cotransporter 2 Inhibitor, as Add-on to Insulin in Patients With Type 1 Diabetes
Robert R. Henry, Payal Thakkar, Cindy Tong, David Polidori, Maria Alba

Diabetes Care Dec 2015, 38 (12) 2258-2265; DOI: 10.2337/dc15-1730
You have access
Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study
Christian S. Frandsen, Thomas F. Dejgaard, Jens J. Holst, Henrik U. Andersen, Birger Thorsteinsson, Sten Madsbad

Diabetes Care Dec 2015, 38 (12) 2250-2257; DOI: 10.2337/dc15-1037
You have access
Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2)
Francesco Giorgino, Marian Benroubi, Jui-Hung Sun, Alan G. Zimmermann, Valeria Pechtner

Diabetes Care Dec 2015, 38 (12) 2241-2249; DOI: 10.2337/dc14-1625
Open Access
How to Accurately Establish Pharmacokinetics/Pharmacodynamics of Long-Acting Insulins in Humans: Relevance to Biosimilar Insulins
Francesca Porcellati, Paola Lucidi, Geremia B. Bolli, Carmine G. Fanelli

Diabetes Care Dec 2015, 38 (12) 2237-2240; DOI: 10.2337/dc15-1848
Open Access
Pharmacokinetics and Pharmacodynamics of Biosimilar Insulins: Is Clamp Technology Fit for Purpose?
Philip Home

Diabetes Care Dec 2015, 38 (12) 2234-2236; DOI: 10.2337/dc15-1046
You have access
Comparison of the Pharmacokinetics and Pharmacodynamics of LY2963016 Insulin Glargine and EU- and US-Approved Versions of Lantus Insulin Glargine in Healthy Subjects: Three Randomized Euglycemic Clamp Studies
Helle Linnebjerg, Eric Chen Quin Lam, Mary E. Seger, David Coutant, Laiyi Chua, Chew Lan Chong, Maria M. Ferreira, Danny Soon, Xin Zhang

Diabetes Care Dec 2015, 38 (12) 2226-2233; DOI: 10.2337/dc14-2623
You have access
New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4)
Philip D. Home, Richard M. Bergenstal, Geremia B. Bolli, Monika Ziemen, Maria Rojeski, Melanie Espinasse, Matthew C. Riddle

Diabetes Care Dec 2015, 38 (12) 2217-2225; DOI: 10.2337/dc15-0249

Main menu

User menu

Search

Insulin After More Than 90 Years

Pages

Navigate

More Information

Other ADA Resources